Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2015

Research Beam added a report “Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2015"

Summary

Global Markets Directs, ‘Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2015, provides an overview of the Post-Traumatic Stress Disorder (PTSD) s therapeutic pipeline.

Enquiry @ http://www.researchbeam.com/post-traumatic-stress-disorder-ptsd-pipeline-review-h2-2015-market/enquire-about-report

This report provides comprehensive information on the therapeutic development for Post-Traumatic Stress Disorder (PTSD) , complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Post-Traumatic Stress Disorder (PTSD) and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news and deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens RandD pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Post-Traumatic Stress Disorder (PTSD)

- The report reviews key pipeline products under drug profile section which includes, product description, MoA and RandD brief, licensing and collaboration details and other developmental activities

- The report reviews key players involved in the therapeutics development for Post-Traumatic Stress Disorder (PTSD) and enlists all their major and minor projects

- The report summarizes all the dormant and discontinued pipeline projects

- A review of the Post-Traumatic Stress Disorder (PTSD) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- A detailed assessment of monotherapy and combination therapy pipeline projects

- Coverage of the Post-Traumatic Stress Disorder (PTSD) pipeline on the basis of target, MoA, route of administration and molecule type

- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective RandD development strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop strategic initiatives by understanding the focus areas of leading companies

- Identify and understand important and diverse types of therapeutics under development for Post-Traumatic Stress Disorder (PTSD)

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Devise corrective measures for pipeline projects by understanding Post-Traumatic Stress Disorder (PTSD) pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table Of Contents

Table of Contents 2

List of Tables 7

List of Figures 8

Introduction 9

Global Markets Direct Report Coverage 9

Post-Traumatic Stress Disorder (PTSD) Overview 10

Therapeutics Development 11

Pipeline Products for Post-Traumatic Stress Disorder (PTSD) - Overview 11

Pipeline Products for Post-Traumatic Stress Disorder (PTSD) - Comparative Analysis 12

Post-Traumatic Stress Disorder (PTSD) - Therapeutics under Development by Companies 13

Post-Traumatic Stress Disorder (PTSD) - Therapeutics under Investigation by Universities/Institutes 15

Post-Traumatic Stress Disorder (PTSD) - Pipeline Products Glance 16

Late Stage Products 16

Clinical Stage Products 17

Early Stage Products 18

Unknown Stage Products 19

Post-Traumatic Stress Disorder (PTSD) - Products under Development by Companies 20

Post-Traumatic Stress Disorder (PTSD) - Products under Investigation by Universities/Institutes 22

Post-Traumatic Stress Disorder (PTSD) - Companies Involved in Therapeutics Development 23

Addex Therapeutics Ltd 23

Azevan Pharmaceuticals, Inc. 24

Catalyst Pharmaceutical Partners, Inc. 25

Eli Lilly and Company 26

HolsboerMaschmeyer NeuroChemie GmbH 27

Humanetics Corporation 28

Intra-Cellular Therapies, Inc. 29

Marinus Pharmaceuticals, Inc. 30

Neuralstem, Inc. 31

Neurocrine Biosciences, Inc. 32

NeuroNascent, Inc. 33

Omeros Corporation 34

Otsuka Holdings Co., Ltd. 35

Pfizer Inc. 36

Polleo Pharma Limited 37

Synchroneuron Inc. 38

Tonix Pharmaceuticals Holding Corp. 39

Vanda Pharmaceuticals Inc. 40

Post-Traumatic Stress Disorder (PTSD) - Therapeutics Assessment 41

Assessment by Monotherapy Products 41

Assessment by Target 42

Assessment by Mechanism of Action 44

Assessment by Route of Administration 46

Assessment by Molecule Type 48

Source: http://www.researchbeam.com/post-traumatic-stress-disorder-ptsd-pipeline-review-h2-2015-market

About Us:

We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities.

In order to survive the fierce competition and locate different avenues, one must be privy to high end and quality market information. So, we try and provide you with latest market information by getting high market research reports from our clients.

Contact Us:

Deep Joshi

5933 NE Win Sivers Drive,

#205, Portland, OR 97220

United States

U.S. & Canada Toll Free: + 1-800-910-6452

International: + 1-503-894-6022

UK: + 44-845-528-1300

India: +91 20 66346070

Fax : +1 (855) 550-5975

Email: help@researchbeam.com/

Web: http://www.researchbeam.com/

Blog: http://www.researchbeam.blogspot.in/